23andMe is a direct-to-consumer (D2C) genetics company that sells ancestry and health DNA testing kits while also offering research and advisory services. We analyzed the company's funding activity, business model, customer acquisition strategy, market size, and competitors.
23andMe is a direct-to-consumer (D2C) genetics company that sells DNA testing kits for ancestry and health insights. It differs from traditional ancestry companies (e.g. Ancestry) by offering a set of FDA-approved health predisposition and wellness reports, which help consumers understand their inherited disease risks along with their ancestry breakdowns.
We analyze 23andMe’s:
